Fodinicurvata Details: NCBI 1121829, gram-negative or unknown [genus]

| Fodinicurvata| Fodinicurvata Wang et al. 2009

  1. Urinary Tract Infections (UTIs): Providencia species, especially Providencia stuartii, are known to be opportunistic pathogens that can cause UTIs, particularly in individuals with compromised immune systems or underlying health conditions. UTIs can manifest with symptoms such as pain during urination, frequent urination, and lower abdominal discomfort.

  2. Gastrointestinal Infections: Providencia species have also been implicated in gastrointestinal infections, leading to symptoms such as diarrhea, abdominal cramps, and nausea.

  3. Hospital-Acquired Infections: Providencia stuartii, in particular, is known for its association with nosocomial or hospital-acquired infections. It is often associated with catheter-related urinary tract infections and can exhibit resistance to multiple antibiotics.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Fodinicurvata

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 0.18 100 117840 0 166508 50015.8 41062 59434.7 100 117840 16.7 %ile 66.7 %ile
thryve 36.19 0 27 1 4632 0 31461 4064.4 99 13977.7 0 3655 0 %ile 91.6 %ile

External Reference Ranges for Fodinicurvata

Fodinicurvata (NCBI 1121829) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Statistic by Lab Source for Fodinicurvata
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
BiomeSightRdp 21.875 %   7.493 %  4.788 % 7.0 32
SequentiaBiotech 2.778 %   0.016 %  % 1.0 36
Thryve 34.657 %   0.44 %  1.561 % 480.0 1385

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

Data Contradictions β€” Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

πŸ§™? Search Hints:
General Substance Specific Substance Effect
Antibiotics, Antivirals etc azithromycin,(antibiotic)s[CFS] 1 Studies recorded. The consensus is Decreases📓, Click for details.
Herb or Spice berberine 1 Studies recorded. The consensus is Decreases📓, Click for details.
Probiotics bacillus amyloliquefaciens (probiotic) 1 Studies recorded. The consensus is Increases📓, Click for details.
Probiotics Prescript Assist (2018 Formula) 1 Studies recorded. The consensus is Increases📓, Click for details.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.